Finance

The SEIV Finance Sector operates as a platform for collaboration and exchange of expertise among the financial executives of member companies, aiming to highlight and address critical financial issues affecting the medical technology and biotechnology sector.

Through the participation of finance directors, financial department executives, and receivables management officers, the Sector contributes to a well-documented understanding of market challenges and the formulation of common positions.

In recent years, the sector has been operating in a particularly demanding economic environment, characterized by:

• payment delays from public sector entities
• high and often unstable levels of rebate and clawback mechanisms
• difficulties in managing uninvoiced and overdue liabilities
• limited predictability in budget planning and cash flow management

The Sector aims to develop well-documented policy proposals and technical solutions addressed to the relevant institutional authorities, contributing to the creation of a more stable and sustainable financial environment for the sector.